Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology

Brain Research

Volumn 1022, Issue 1-2, 2004, Pages 164-172

  Conn, Kelly J ^a,b   Gao, Wenwu ^a,b   McKee, Ann ^a,b   Lan, Michael S ^c   Ullman, M David ^a,d   Eisenhauer, Patricia B ^a,b,d   Fine, Richard E ^a,b   Wells, John M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

1 Methyl 4 phenyl pyridinium; Dementia with Lewy bodies; Lewy body; Pancreatic protein disulfide isomerase; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; LACTACYSTIN; PROTEIN DISULFIDE ISOMERASE; PYRIDINIUM DERIVATIVE; RETINOIC ACID; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEWY BODY; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYLPYRIDINIUM; ACETYLCYSTEINE; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOPAMINE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MALE; MIDDLE AGED; NEUROBLASTOMA; NUCLEAR PROTEINS; PARKINSONIAN DISORDERS; POSTMORTEM CHANGES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRETINOIN;

EID: 4444237848     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.07.026     Document Type: Article

References (36)

1. A.K. Bence, and P.A. Crooks The mechanism of l-canavanine cytotoxicity: arginyl tRNA synthetase as a novel target for anticancer drug discovery J. Enzyme Inhib. Med. Chem. 18 2003 383 394
2. T.L. Burgess, and R.B. Kelly Constitutive and regulated secretion of proteins Annu. Rev. Cell Biol. 3 1987 243 293
3. +-treated SH-SY5Y cells J. Neurosci. Res. 68 2001 755 760
4. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
5. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822
6. M.G. Desilva, J. Lu, G. Donadel, W.S. Modi, H. Xie, A.L. Notkins, and M.S. Lan Characterization and chromosomal localization of a new protein disulfide isomerase, PDIp, highly expressed in human pancreas DNA Cell Biol. 15 1996 9 16
7. M.G. Desilva, A.L. Notkins, and M.S. Lan Molecular characterization of a pancreas-specific protein disulfide isomerase PDIp, DNA Cell Biol. 16 1997 269 274
8. A.P. Doskeland, and T. Flatmark Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form Eur. J. Biochem. 269 2002 1561 1569
9. G. Fenteany, and S.L. Schreiber Lactacystin, proteasome function, and cell fate J. Biol. Chem. 273 1998 8545 8548
10. D.M. Ferrari, and H.D. Soling The protein disulphide-isomerase family: unravelling a string of folds Biochem. J. 339 Pt 1 1999 1 10
11. L.S. Forno Neuropathology of Parkinson's disease J. Neuropathol. Exp. Neurol. 55 1996 259 272
12. R.B. Freedman, T.R. Hirst, and M.F. Tuite Protein disulphide isomerase: building bridges in protein folding Trends Biochem. Sci. 19 1994 331 336
13. W.R. Gibb, and A.J. Lees The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J. Neurol. Neurosurg. Psychiatry 51 1988 745 752
14. B. Halliwell Hypothesis: proteasomal dysfunction: a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death Ann. N.Y. Acad. Sci. 962 2002 182 194
15. A. Hershko, and A. Ciechanover The ubiquitin system Annu. Rev. Biochem. 67 1998 425 479
16. M. Hochstrasser Ubiquitin-dependent protein degradation Annu. Rev. Genet. 30 1996 405 439
17. W.A. Holtz, and K.L. O'Malley Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons J. Biol. Chem. 278 2003 19367 19377
18. R.J. Kaufman Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls Genes Dev. 13 1999 1211 1233
19. P. Klappa, R.B. Freedman, M. Langenbuch, M.S. Lan, G.K. Robinson, and L.W. Ruddock The pancreas-specific protein disulphide-isomerase PDIp interacts with a hydroxyaryl group in ligands Biochem. J. 354 2001 553 559
20. R.R. Kopito, and R. Sitia Aggresomes and Russell bodies, Symptoms of cellular indigestion? EMBO Rep. 1 2000 225 231
21. A.E. Lang, and A.M. Lozano Parkinson's disease. Second of two parts N. Engl. J. Med. 339 1998 1130 1143
22. N. Lenny M.Green, Regulation of endoplasmic reticulum stress proteins in COS cells transfected with immunoglobulin mu heavy chain cDNA J. Biol. Chem. 266 1991 20532 20537
23. U.G. Lopes, P. Erhardt, R. Yao, and G.M. Cooper p53-dependent induction of apoptosis by proteasome inhibitors J. Biol. Chem. 272 1997 12893 12896
24. R.A. Mazzarella, N. Marcus, S.M. Haugejorden, J.M. Balcarek, J.J. Baldassare, B. Roy, L.J. Li, and A.S. Lee M. Green, Erp61 is GRP58, a stress-inducible luminal endoplasmic reticulum protein, but is devoid of phosphatidylinositide-specific phospholipase C activity Arch. Biochem. Biophys. 308 1994 454 460
25. K.S. McNaught, C.W. Olanow, B. Halliwell, O. Isacson, and P. Jenner Failure of the ubiquitin-proteasome system in Parkinson's disease Nat. Rev., Neurosci. 2 2001 589 594
26. K.S. McNaught, C. Mytilineou, R. Jnobaptiste, J. Yabut, P. Shashidharan, P. Jennert, and C.W. Olanow Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures J. Neurochem. 81 2002 301 306
27. M. Molinari, C. Galli, V. Piccaluga, M. Pieren, and P. Paganetti Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER J. Cell Biol. 158 2002 247 257
28. R. Noiva, R.B. Freedman, and W.J. Lennarz Peptide binding to protein disulfide isomerase occurs at a site distinct from the active sites J. Biol. Chem. 268 1993 19210 19217
29. M.S. Pollanen, D.W. Dickson, and C. Bergeron Pathology and biology of the Lewy body J. Neuropathol. Exp. Neurol. 52 1993 183 191
30. S. Przedborski, and M. Vila The 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease Ann. N.Y. Acad. Sci. 991 2003 189 198
31. E.J. Ryu, H.P. Harding, J.M. Angelastro, O.V. Vitolo, D. Ron, and L.A. Greene Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease J. Neurosci. 22 2002 10690 10698
32. M.Y. Sherman, and A.L. Goldberg Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases Neuron 29 2001 15 32
33. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies Proc. Natl. Acad. Sci. U. S. A. 95 1998 6469 6473
34. C. Turano, S. Coppari, F. Altieri, and A. Ferraro Proteins of the PDI family: unpredicted non-ER locations and functions J. Cell. Physiol. 193 2002 154 163
35. E.M. Valente, P.M. bou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, S. Gispert, Z. Ali, T.D. Del, A.R. Bentivoglio, D.G. Healy, A. Albanese, R. Nussbaum, R. Gonzalez-Maldonado, T. Deller, S. Salvi, P. Cortelli, W.P. Gilks, D.S. Latchman, R.J. Harvey, B. Dallapiccola, G. Auburger, and N.W. Wood Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
36. D. Voges, P. Zwickl, and W. Baumeister The 26S proteasome: a molecular machine designed for controlled proteolysis Annu. Rev. Biochem. 68 1999 1015 1068